title: Role of pharmacogenetics in the use of CNS drugs: from drug pipeline to primary care?
authors.forename: Michael M
authors.initials: MM
authors.lastname: Hopkins
authors.forename: Paul A
authors.initials: PA
authors.lastname: Martin
mesh_terms: D002491:Central Nervous System Agents / Q000627:therapeutic use*; D015195:Drug Design; D020022:Genetic Predisposition to Disease / Q000235:genetics / Q000517:prevention & control; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy* / Q000235:genetics; D009422:Nervous System Diseases / Q000188:drug therapy* / Q000235:genetics; D010597:Pharmacogenetics / Q000639:trends*; D010818:Practice Patterns, Physicians' / Q000639:trends; D011320:Primary Health Care / Q000639:trends*
chemical_list: D002491:Central Nervous System Agents